Products and Resources - SAMHSA Reporting

The purpose of this introductory training is to provide HIV clinicians with a detailed overview of the neurobiology of addiction, the impact of HIV on the brain and central nervous system (CNS), and the detrimental impact of the intersectionality of multiple stigmatized identities. This training is a companion to, and can be conducted in conjunction with the “How Change Happens: Substance Use Disorders and HIV/AIDS” training curriculum.

The purpose of this training is to provide HIV clinicians with an overview of the challenges and strategies for change in working with individuals living with HIV/AIDS and a diagnosis of a substance use disorder. This training is a companion to and can be conducted in conjunction with the “Nature of Addiction and HIV” training curriculum.

The July 2018 Dialogue discusses the STR-TA Consortium, Minority Mental Health Month, awareness events, Central East on the Move, and regional news.

In this webinar, Joe Glass, PhD, MSW, of Kaiser Permanente WA Health Research Institute, examined the stigma of substance use disorders. Dr. Glass reviewed the scientific evidence about how stigma shapes healthcare experiences and treatment seeking, and discussed practical issues such as why and how to avoid using stigmatizing language.

This manual was developed as part of a PhD by the South Africa HIV ATTC Co-Director, Dr. Goodman Sibeko. Initial piloting took place at two non-profit organizations after ethical approval was obtained from the Human Research Ethics Committee (913/205) of the University of Cape Town.The manual now serves as the basis of the training approach used by the South Africa HIV ATTC to help organisations improve mental health care as a means of reducing HIV risk and improving HIV treatment outcomes.

This manuscript describes a pilot study of the mental health training manual used by the South Africa HIV ATTC. Results indicated that community health workers demonstrated significantly improved knowledge, confidence, attitudes, and tolerance to rehabilitation of the mentally ill in the community. The manuscript was written by Dr. Goodman Sibeko, the South Africa HIV ATTC Co-Director, and Professor Dan Stein, the Project Director, and published June 2018 in BMC Psychiatry.

This presentation provides an overview of drug and alcohol use in South Africa, with a particular focus on people living with HIV. Additionally, the South Africa HIV ATTC's mission, objectives, and training targets are contextualised within this drug and alcohol addiction context.

This presentation discusses strategies to identify South Africa HIV ATTC training and technical assistance offerings that meet stakeholder needs, particularly with mental health and substance use topics. We particularly focus on the Screening, Brief Intervention, and Referral to Treatment (SBIRT) training model.

A presentation on Behavioral Therapies for Methamphetamine Use, presented by Will M. Aklin, PhD of the National Institute on Drug Abuse Division of Therapeutics and Medical Consequences on June 27, 2017.

Recovery Support Services Project Fiscal Year 2017 Final Evaluation Report

This is a one-page flyer detailing the objectives, mission and contact information of the South Africa HIV ATTC.

This National Workforce Report provides strategies for recruitment, retention, and development of the substance use disorder treatment and recovery services workforce. This report is based is based on a series of telephone interviews conducted in 2015 and 2016 with 44 Single State Agencies and the clinical directors and other staff representing nearly 70 substance use disorder (SUD) treatment agencies across the United States.

Eight, 1-page color infographics (Four in English, four in Spanish) covering 1) Effects on the body 2) Use and educational outcomes, 3) Effects on pregnancy and newborns, and 4) Medical use.

In this webinar, Dr. Hill discusses the major myths about marijuana use and the challenges of treating marijuana addiction, including working with parents.

Q&A with marijuana expert Dr. Kevin Hill. Topics include Addiction/dependency, adolescence, effects on the body, medical marijuana, potency, and withdrawal.

Electronic newsletter

Dr. Wilson M. Compton, Deputy Director at NIDA, highlights the adverse effects of marijuana use can have on the brain, heart, and respiratory. The video also provides some information on second hand exposure and current marijuana potency.

Dr. Kari Franson from the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences shares information on the long-term negative outcomes marijuana use has on developing adolescents.

Dr. Yifrah Kaminer from the University of Connecticut Health gives an overview of the latest research on the marijuana's effects on the brain and how legalization affects states' SUD treatment and prevention systems.

Dr. Laura Borgelt, Professor at the University of Colorado Skaggs School of Pharmacy, discusses the effects marijuana use can have on women who are pregnant, breastfeeding, the unborn child, and newborns.

Dr. Thomas E. Freese, Director of the Pacific Southwest ATTC, explains what is meant by "medical" marijuana, who uses it and why, and the difference between medical marijuana and FDA approved medications.

Under Federal law, marijuana is still an illegal substance, yet 23 states and Washington DC have legalized medical marijuana, and four states have decriminalized marijuana for recreational use. With this shift in policy and many other states expected to follow suit, we will need to consider ways to address the growing impact and consequences of legalization. Dr. Rosalie Pacula, Director of the Bing Center for Health Economics at the RAND Corporation, will examine in this video the variance

Two-page fact sheet with facts about Marijuana and its use as well as its effects on the body, tips for cutting back, and helpful links.

Reference reading list of sources for HIV clinicians concerning medical marijuana.